BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10370187)

  • 21. Relative therapeutic index between inhaled formoterol and salbutamol in asthma patients.
    Rosenborg J; Larsson R; Rott Z; Böcskei C; Poczi M; Juhász G
    Respir Med; 2002 Jun; 96(6):412-7. PubMed ID: 12117040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and tolerability of high-dose formoterol (Aerolizer) and salbutamol (pMDI) in patients with mild/moderate, persistent asthma.
    Kruse M; Rosenkranz B; Dobson C; Ayre G; Horowitz A
    Pulm Pharmacol Ther; 2005; 18(3):229-34. PubMed ID: 15707858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer.
    Seppälä OP; Herrala J; Hedman J; Alanko K; Liipo K; Terho E; Pietinalho A; Nyholm JE; Nieminen MM
    Respir Med; 1998 Mar; 92(3):578-83. PubMed ID: 9692126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and potency of ipratropium via Turbuhaler and pressurized metered-dose inhaler in reversible airflow obstruction.
    Böllert FG; Matusiewicz SP; Dewar MH; Brown GM; McLean A; Greening AP; Crompton GK
    Eur Respir J; 1997 Aug; 10(8):1824-8. PubMed ID: 9272926
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of bronchodilator responses of levosalbutamol and salbutamol given via a pressurized metered dose inhaler: a randomized, double blind, single-dose, crossover study.
    Jantikar A; Brashier B; Maganji M; Raghupathy A; Mahadik P; Gokhale P; Gogtay J; Salvi S
    Respir Med; 2007 Apr; 101(4):845-9. PubMed ID: 17276051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Onset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPD.
    Cazzola M; Centanni S; Regorda C; di Marco F; di Perna F; Carlucci P; Boveri B; Santus P
    Pulm Pharmacol Ther; 2001; 14(1):41-5. PubMed ID: 11162418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salbutamol dry powder inhaler: efficacy, tolerability, and acceptability study.
    O'Callaghan C; Everard ML; Bush A; Hiller EJ; Ross-Russell R; O'Keefe P; Weller P
    Pediatr Pulmonol; 2002 Mar; 33(3):189-93. PubMed ID: 11836798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of salbutamol via Easyhaler unaffected by low inspiratory flow.
    Koskela T; Malmström K; Sairanen U; Peltola S; Keski-Karhu J; Silvasti M
    Respir Med; 2000 Dec; 94(12):1229-33. PubMed ID: 11192960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative efficacy of three different inhalers containing salbutamol in patients with asthma.
    Mahadewsingh JV; Hamersma WB; Schreurs AJ
    Eur J Clin Pharmacol; 1996; 50(6):467-9. PubMed ID: 8858273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the efficacy and tolerability of single doses of HFA 134a albuterol and CFC albuterol in mild-to-moderate asthmatic patients.
    Langley SJ; Sykes AP; Batty EP; Masterson CM; Woodcock A
    Ann Allergy Asthma Immunol; 2002 May; 88(5):488-93. PubMed ID: 12027070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Spacehaler for delivery of salbutamol: a comparison with the standard metered-dose inhaler plus Volumatic spacer device.
    Gunawardena KA; Sohal T; Jones JI; Upchurch FC; Crompton GK
    Respir Med; 1997 May; 91(5):311-6. PubMed ID: 9176650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of Albuterol (Salbuterol) Multi-dose Dry-Powder Inhaler and ProAir(®) Hydrofluoroalkane for the Treatment of Persistent Asthma: Results of Two Randomized Double-Blind Studies.
    Kerwin EM; Taveras H; Iverson H; Wayne D; Shah T; Lepore MS; Miller DS
    Clin Drug Investig; 2016 Jan; 36(1):55-65. PubMed ID: 26541599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial.
    Noonan M; Rosenwasser LJ; Martin P; O'Brien CD; O'Dowd L
    Drugs; 2006; 66(17):2235-54. PubMed ID: 17137405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilating effects of salbutamol from a novel inhaler Airmax.
    Middle MV; Terblanché J; Perrin VL; Hertog MG
    Respir Med; 2002 Jul; 96(7):493-8. PubMed ID: 12194632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of cumulative doses of salbutamol administered via Turbuhaler or Diskhaler in patients with reversible airway obstruction.
    Carlsson LG; Arweström E; Friberg K; Källén A; Lunde H; Löfdahl CG
    Allergy; 1998 Jul; 53(7):712-5. PubMed ID: 9700042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.
    Müller V; Gálffy G; Orosz M; Kováts Z; Odler B; Selroos O; Tamási L
    Int J Chron Obstruct Pulmon Dis; 2016; 11():93-101. PubMed ID: 26834466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.